Lyell Immunopharma, Inc. (LYEL) Presents at H.C. Wainwright 4th Annual BioConnect Investor Conference Transcript
Lyell Immunopharma, Inc. presented at the H.C. Wainwright 4th Annual BioConnect Investor Conference. CEO Lynn Seely discussed the company's initiatives in the CD19/20 space and colorectal cancer. The presentation included an overview of current data and future plans.
- ▪Lyell Immunopharma, Inc. is focused on advancing therapies in the CD19/20 space.
- ▪The company is actively working on initiatives related to colorectal cancer.
- ▪Lynn Seely, the CEO, provided insights into the company's current data and future strategies.
2 outlets in our directory ran this story, first to last over 2 hours. All of the coverage we found sits in one bucket: centre. That one-sidedness is itself worth noticing.
- ▪ Nuvation Bio Inc. (NUVB) Presents at H.C. Wainwright 4th Annual BioConnect Investor Conference Transcript — All Articles on Seeking Alpha
Seeking Alpha files mainly under finance. We currently carry 6,317 of its stories.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4908145-lyell-immunopharma-inc-lyel-presents-at-h-c-wainwright-4th-annual-bioconnect-investor"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
